drugset / Trial / NCT06079541
Phase 1 Clinical Study of JMKX003142 Tablets
RandomizedParallel-groupQuadruple-blindBasic science
Summary
Phase I clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of JMKX003142 tablets administered randomly, double-blind, placebo-controlled single and multiple times in healthy adult subjects, as well as the effects of randomized, open, and two cycle crossover foods
Timeline
- Start
- 2023-07-06
- Primary completion
- 2024-07-31
- Completion
- 2025-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JMKX003142 | Unknown | — | Oral |
Indications
No indication recorded.